Vivos Inc. (RDGL) News
Track canonical SquawkNews coverage tagged to RDGL, Vivos Inc.. This hub brings together deduplicated headlines about otc markets otcqb, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Vivos Inc. announces peer-reviewed PrecisionGel™ polymer platform paper
Vivos Inc. (OTCQB: RDGL) said a peer-reviewed paper describing its PrecisionGel™ thermogel polymer platform was published in Elsevier’s Journal of Drug Delivery Science and Technology.
EQUITY | Sep 03, 2026, 12:08 PM UTC
L
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study
Kennewick, WA, July 06, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL
EQUITY | Jul 06, 2026, 12:30 PM UTC